Natera, Inc. (NTRA) Shares Sold by Nationwide Fund Advisors

Nationwide Fund Advisors lessened its holdings in shares of Natera, Inc. (NASDAQ:NTRA) by 71.5% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 17,737 shares of the medical research company’s stock after selling 44,536 shares during the period. Nationwide Fund Advisors’ holdings in Natera were worth $193,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Jennison Associates LLC raised its position in shares of Natera by 1.0% during the 2nd quarter. Jennison Associates LLC now owns 2,356,346 shares of the medical research company’s stock worth $25,590,000 after acquiring an additional 23,473 shares in the last quarter. Vanguard Group Inc. raised its position in shares of Natera by 4.4% during the 1st quarter. Vanguard Group Inc. now owns 2,007,708 shares of the medical research company’s stock worth $17,808,000 after acquiring an additional 84,144 shares in the last quarter. Bank of New York Mellon Corp raised its position in shares of Natera by 1.5% during the 2nd quarter. Bank of New York Mellon Corp now owns 634,743 shares of the medical research company’s stock worth $6,893,000 after acquiring an additional 9,223 shares in the last quarter. Contrarius Investment Management Ltd raised its position in shares of Natera by 1.4% during the 2nd quarter. Contrarius Investment Management Ltd now owns 480,944 shares of the medical research company’s stock worth $5,223,000 after acquiring an additional 6,491 shares in the last quarter. Finally, Kornitzer Capital Management Inc. KS raised its position in shares of Natera by 22.2% during the 2nd quarter. Kornitzer Capital Management Inc. KS now owns 436,290 shares of the medical research company’s stock worth $4,738,000 after acquiring an additional 79,325 shares in the last quarter. 60.54% of the stock is currently owned by institutional investors and hedge funds.

Natera, Inc. (NTRA) opened at $9.40 on Thursday. Natera, Inc. has a 12-month low of $7.35 and a 12-month high of $14.76. The company has a debt-to-equity ratio of 2.43, a current ratio of 1.85 and a quick ratio of 1.75.

Natera (NASDAQ:NTRA) last released its quarterly earnings results on Wednesday, November 8th. The medical research company reported ($0.51) EPS for the quarter, missing the consensus estimate of ($0.47) by ($0.04). The firm had revenue of $56.66 million for the quarter, compared to analyst estimates of $55.31 million. Natera had a negative return on equity of 197.09% and a negative net margin of 62.34%. The company’s quarterly revenue was up 5.1% on a year-over-year basis. During the same period last year, the firm earned ($0.50) EPS. equities analysts anticipate that Natera, Inc. will post -2.15 earnings per share for the current year.

Several equities research analysts have recently weighed in on NTRA shares. Zacks Investment Research lowered Natera from a “buy” rating to a “hold” rating in a research report on Thursday, October 26th. BidaskClub raised Natera from a “sell” rating to a “hold” rating in a research report on Wednesday, August 23rd. ValuEngine raised Natera from a “strong sell” rating to a “sell” rating in a research report on Thursday, August 10th. Finally, Morgan Stanley cut their price target on Natera from $18.00 to $13.00 and set an “overweight” rating on the stock in a research report on Monday, August 7th. Two research analysts have rated the stock with a sell rating, one has given a hold rating and four have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus price target of $15.00.

TRADEMARK VIOLATION NOTICE: “Natera, Inc. (NTRA) Shares Sold by Nationwide Fund Advisors” was published by Markets Daily and is the sole property of of Markets Daily. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international copyright and trademark legislation. The legal version of this article can be accessed at https://www.themarketsdaily.com/2017/11/16/natera-inc-ntra-shares-sold-by-nationwide-fund-advisors.html.

In other Natera news, insider Jonathan Sheena sold 120,000 shares of Natera stock in a transaction that occurred on Wednesday, September 6th. The stock was sold at an average price of $12.54, for a total value of $1,504,800.00. Following the transaction, the insider now directly owns 533,208 shares in the company, valued at approximately $6,686,428.32. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 12.57% of the company’s stock.

Natera Company Profile

Institutional Ownership by Quarter for Natera (NASDAQ:NTRA)

Receive News & Ratings for Natera Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natera Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply